Green tea for B-cell malignancies . . .
The authors of this study previously reported that epigallocatechin gallate (EGCG), a polyphenol in green tea, induced apoptotic cell death in leukemic B-cells from a majority of patients with chronic lymphocytic leukemia (CLL). After the publication of these findings, many patients with CLL and other low grade lymphomas began using over-the-counter products containing tea polyphenols. Four patients with low grade B-cell malignancies (three with CLL and one with B-cell lymphoma) were seen in the authors' clinical practice who began oral self-treatment with EGCG-containing products and subsequently appeared to have an objective clinical response. Three of the four patients met standard criteria for a partial response. Some of these patients had had steady clinical, laboratory, and/or radiographic evidence of progression prior to taking tea polyphenols and developed objective responses shortly after starting the treatment.
Comment: While the possibility of spontaneous remissions cannot be ruled out, such remissions are rare in patients with low grade B-cell malignancies. Although confirmatory studies are needed before this treatment can be considered proven, there seems to be little risk, and a great deal of potential benefit, from the use of tea polyphenols by patients with low-grade B-cell malignancies.
Shanafelt TD, et al. Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res. 2006;30:707-712.
